ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,867, issued on Aug. 11, was assigned to RIKEN (Saitama, Japan).
"Cell capable of activating immune system, and pharmaceutical composition containing said cell" was invented by Shinichiro Fujii (Saitama, Japan) and Kanako Shimizu (Saitama, Japan).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a cell activating the immune system and a pharmaceutical composition containing the cell. According to the present invention, there is provided a mammalian cell having at least one protein selected from the group consisting of E6 protein and E7 protein for early genes of human papillomavirus and a fusion protein of E6 protein and E7...